Retour sur lavenir.net
   NYXOAH 2.820 € (+5,42 %)     ARGENX SE 641.200 € (-0,71 %)     FAGRON 21.900 € (+0,46 %)     ELIA GROUP 134.000 € (0,00 %)     AGEAS 64.350 € (0,00 %)     ASCENCIO 49.050 € (+0,72 %)     SHURGARD 25.450 € (-0,78 %)     SOFINA 211.800 € (-1,40 %)     AB INBEV 61.220 € (+0,79 %)     SYENSQO 48.590 € (-1,46 %)     KBC 107.700 € (-1,96 %)     LOTUS BAKERIES 9 840.000 € (-0,61 %)     BEKAERT 39.450 € (-2,83 %)     ACKERMANS V.HAAREN 269.200 € (-0,74 %)     BPOST 1.828 € (-1,61 %)     TESSENDERLO 20.100 € (-2,66 %)     UMICORE 16.220 € (-2,17 %)     KINEPOLIS GROUP 26.400 € (-0,38 %)     PROXIMUS 6.960 € (-1,83 %)     ONWARD MEDICAL 3.250 € (-4,83 %)     MONTEA 67.000 € (-0,30 %)     UCB 262.700 € (-1,90 %)     AEDIFICA 71.200 € (+0,14 %)     IMMOBEL 21.850 € (+1,63 %)     MELEXIS 53.550 € (-2,37 %)     WDP 23.280 € (-0,09 %)     VIOHALCO 12.840 € (-2,73 %)     AZELIS GROUP 8.840 € (+0,91 %)     D'IETEREN GROUP 161.900 € (-1,64 %)     GIMV 45.500 € (-0,44 %)     COLRUYT 35.760 € (+1,25 %)     TUBIZE-FIN 215.000 € (-1,38 %)     DEME GROUP 187.400 € (-1,88 %)     CENERGY 19.320 € (-0,92 %)     RECTICEL 9.680 € (-1,43 %)     BANQUP GROUP 3.000 € (-1,64 %)     KBC ANCORA 71.900 € (-1,51 %)     VAN DE VELDE 30.200 € (-1,63 %)     ORANGE BELGIUM 20.500 € (0,00 %)     SOLVAY 27.060 € (+1,20 %)     HOME INVEST BE. 18.660 € (+0,97 %)     TINC 11.680 € (+0,34 %)     IBA 12.800 € (-2,29 %)     OXURION 0.005 € (-14,29 %)     CMB.TECH 10.800 € (-1,10 %)     ONTEX GROUP 3.420 € (+2,86 %)     BREDERODE 102.000 € (-0,78 %)     AGFA-GEVAERT 0.485 € (-0,82 %)     DECEUNINCK 2.045 € (-0,97 %)     OPTION 5.796 € (+5,38 %)     CAMPINE 195.000 € (0,00 %)     VGP 85.400 € (-1,73 %)     BIOTALYS 1.855 € (+5,40 %)     BQUE NAT. BELGIQUE 410.000 € (+1,99 %)     GBL 78.150 € (-0,51 %)     BARCO 9.335 € (-1,94 %)     ATENOR 1.700 € (-3,95 %)     HYLORIS 5.000 € (-1,96 %)     CELYAD ONCOLOGY 0.320 € (+1,91 %)     XIOR 26.900 € (0,00 %)  
   VIRIDIEN 128.900 € (+4,20 %)     STIF 42.800 € (-1,95 %)     LOUIS HACHETTE 1.625 € (+2,78 %)     ATON 0.006 € (+3,33 %)     LIGHTON 4.850 € (-4,72 %)     CVC CAPITAL 11.100 € (-2,63 %)     AUBAY 43.150 € (-2,27 %)     2CRSI 27.550 € (-6,13 %)     JDE PEET'S 31.800 € (-0,06 %)     ALSTOM 24.040 € (-3,38 %)     FERMENTALG 0.527 € (-1,86 %)     SANOFI 82.650 € (-0,27 %)     LVMH 468.450 € (-0,56 %)     AIRBUS 164.340 € (-2,12 %)     TOTALENERGIES 79.830 € (+2,93 %)     LEGRAND 134.450 € (-2,82 %)     EO2 2.720 € (-4,90 %)     LATECOERE 0.021 € (+5,05 %)     UNILEVER 48.185 € (-0,24 %)     L'OREAL 356.150 € (-0,28 %)     RENAULT 30.210 € (+0,57 %)     GALP ENERGIA-NOM 21.170 € (+4,03 %)     BNP PARIBAS ACT.A 83.420 € (-2,30 %)     VALNEVA 2.726 € (-3,40 %)     VALLOUREC 21.970 € (+1,85 %)     ENGIE 28.690 € (+1,02 %)     SHELL PLC 40.800 € (+3,23 %)     AMUNDI 74.400 € (-1,91 %)     BRUNEL INTERNAT 6.610 € (-0,60 %)     SIDETRADE 147.500 € (-4,53 %)     SCHNEIDER ELECTRIC 231.450 € (-3,54 %)     PERNOD RICARD 63.500 € (-0,13 %)     GENFIT 8.570 € (-0,70 %)     ASML HOLDING 1 136.000 € (-4,34 %)     PLUXEE 10.750 € (+1,51 %)     AHOLD DEL 41.670 € (+1,14 %)     CTP 15.300 € (-0,91 %)     MAISONS DU MONDE 1.184 € (-8,92 %)     AXA 40.060 € (-0,27 %)     SAFRAN 286.000 € (-1,58 %)     CHRISTIAN DIOR 446.800 € (-0,71 %)     PARROT 10.200 € (+0,99 %)     MOTA ENGIL 4.630 € (-1,95 %)     EMOVA GROUP 0.630 € (-1,56 %)     DANONE 69.580 € (+0,75 %)     ING GROEP N.V. 22.883 € (-1,52 %)     POXEL 0.294 € (-7,84 %)     IMCD 89.640 € (+1,01 %)     KPN KON 4.791 € (+0,46 %)     ADYEN 841.600 € (-2,56 %)     CREDIT AGRICOLE 16.340 € (-1,45 %)     BAM GROEP KON 8.780 € (-5,64 %)     ARCELORMITTAL SA 45.210 € (-3,11 %)     ALLFUNDS GROUP 8.545 € (-0,06 %)     ASM INTERNATIONAL 647.400 € (-3,89 %)     AIR LIQUIDE 180.060 € (+0,03 %)     SODEXO 45.480 € (+0,09 %)     SARTORIUS STED BIO 164.700 € (-1,79 %)     VINCI 131.050 € (-1,17 %)     STMICROELECTRONICS 28.840 € (-3,66 %)  
News Réglementées
12/03/2026 09:00

Original-Research: Deutsche Beteiligungs AG (von NuWays AG): BUY

Original-Research: Deutsche Beteiligungs AG - from NuWays AG

12.03.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Deutsche Beteiligungs AG

Company Name:Deutsche Beteiligungs AG
ISIN:DE000A1TNUT7
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 39
Target price on sight of:12 months
Last rating change:
Analyst:Christian Sandherr

Solid FY25 results, all eyes on deal flow; chg. est.

DBAG released solid FY25 figures, meeting the midpoint of its NAV/share guidance but the higher end of EBITA Fund Investment Services guidance. Deal flow in the short- to mid-term is likely to remain high thanks to increased interest in “old school” industries.

NAV/share came in at € 36.37 (eNuW: € 36.00), up 1.6% yoy. Including the amount returned to shareholders (dividend and buyback), the NAV/share would have increased 7.4% to € 38.44 thanks to the duagon exit and several valuation uplifts. FY26 guidance: NAV/share of €36-40 (eNuW: € 38.49), depending on the scope of successful exits. Management also gave a mid-term (FY28) guidance, expecting a NAV/share of € 41-48 (eNuW: € 45.95), implying a 4-9.7% CAGR.

FY25 EBITA from Fund Investment Services of € 14.3m came in at the upper end of the guidance (€ 10-15m), yet below last year’s € 16.2m due to an increased number of FTE. Lower anticipated AUM/AUA are seen to trigger the guided EBITA decline to € 5-9m (eNuW: € 6.5m) as per the mechanics of private equity, the segment only recovers meaningfully once a new fund is launched. For FY28e, management hence expects EBITA of € 11-17m (eNuW: € 13.2m), likely contingent on the expected launch of DBAG Fund IX, a key catalyst.

Exit pipeline maturing. Management flagged several portfolio companies at a 'high degree of maturity.' The most likely candidates are older DBAG Fund VI holdings, the fund dates to 2013 and has effectively reached end-of-fund-life, creating LP pressure for capital distributions. In fact, DBAG announced the sale of Kraft & Bauer, a fire protection systems maker for machine tools held via DBAG Fund VII since 2018, to Syngroh Capital, marking DBAG's fifth transaction in six months. While concrete deal terms were not published, we expect the IRR within the company’s return expectations, again underpinning the inherent robustness of the reported NAV.

The right portfolio as investor interest shifts. 30-40% of DBAG's portfolio comprises industrial technology, infrastructure, energy and environment, sectors that spent a decade in the shadow of high-growth software. That's changing: AI-driven uncertainty is pushing investors back toward cash-generative, asset-backed industrials, while Germany's € 500bn infrastructure fund adds a structural demand tailwind to precisely these sectors.

For DBAG, the timing is favourable. These holdings sit in older funds approaching end-of-life, meaning exit processes are imminent in order to facilitate the expected fundraising for a new fund. Recovering buyer appetite means carrying values can actually be realised, removing the key bear case that legacy book values were aspirational rather than achievable.

Buyback extended. At the end of February, DBAG extended its initial € 20m buyback program until the end of July. Upon the announced extension, some € 5.8m remained. At a ~35% discount to NAV, every euro of buyback is accretive to remaining shareholders. Combined with the €1.00/share proposed dividend, DBAG runs a compelling dual-return engine into 2026.

We confirm our BUY rating with an unchanged € 39 PT based on SOTP (DCF for Fund Services + discount to our NAV per share estimate at year-end).

You can download the research here: deutsche-beteiligungs-ag-2026-03-12-previewreview-en-9841c
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2290108  12.03.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière